vs
R F INDUSTRIES LTD（RFIL）与ARS Pharmaceuticals, Inc.（SPRY）财务数据对比。点击上方公司名可切换其他公司
ARS Pharmaceuticals, Inc.的季度营收约是R F INDUSTRIES LTD的1.2倍（$28.1M vs $22.7M），R F INDUSTRIES LTD净利率更高（0.8% vs -147.1%，领先147.9%），R F INDUSTRIES LTD同比增速更快（22.9% vs -67.6%）
妥思卷工业是一家总部位于美国伊利诺伊州芝加哥的糖果制造商，旗下最知名的产品包括同名的Tootsie Roll软糖以及Tootsie Pop棒棒糖，目前其品牌产品销往加拿大、墨西哥等全球超过75个国家。
ARS Pharmaceuticals是一家处于后期研发阶段的生物制药企业，专注于开发和商业化严重过敏反应创新疗法，核心产品为无需注射的肾上腺素鼻腔递送制剂，主要面向北美市场，服务存在致命过敏风险的成人及儿童患者群体。
RFIL vs SPRY — 直观对比
营收规模更大
SPRY
是对方的1.2倍
$22.7M
营收增速更快
RFIL
高出90.5%
-67.6%
净利率更高
RFIL
高出147.9%
-147.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $22.7M | $28.1M |
| 净利润 | $173.0K | $-41.3M |
| 毛利率 | 36.8% | — |
| 营业利润率 | 4.0% | -147.6% |
| 净利率 | 0.8% | -147.1% |
| 营收同比 | 22.9% | -67.6% |
| 净利润同比 | 172.7% | -182.8% |
| 每股收益（稀释后） | $0.01 | $-0.41 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收RFILSPRY
| Q4 25 | $22.7M | $28.1M | ||
| Q3 25 | $19.8M | $32.5M | ||
| Q2 25 | $18.9M | $15.7M | ||
| Q1 25 | $19.2M | $8.0M | ||
| Q4 24 | $18.5M | $86.6M | ||
| Q3 24 | $16.8M | $2.1M | ||
| Q2 24 | $16.1M | $500.0K | ||
| Q1 24 | $13.5M | $0 |
净利润RFILSPRY
| Q4 25 | $173.0K | $-41.3M | ||
| Q3 25 | $392.0K | $-51.2M | ||
| Q2 25 | $-245.0K | $-44.9M | ||
| Q1 25 | $-245.0K | $-33.9M | ||
| Q4 24 | $-238.0K | $49.9M | ||
| Q3 24 | $-705.0K | $-19.1M | ||
| Q2 24 | $-4.3M | $-12.5M | ||
| Q1 24 | $-1.4M | $-10.3M |
毛利率RFILSPRY
| Q4 25 | 36.8% | — | ||
| Q3 25 | 34.0% | — | ||
| Q2 25 | 31.5% | — | ||
| Q1 25 | 29.8% | — | ||
| Q4 24 | 31.3% | — | ||
| Q3 24 | 29.5% | — | ||
| Q2 24 | 29.9% | — | ||
| Q1 24 | 24.5% | — |
营业利润率RFILSPRY
| Q4 25 | 4.0% | -147.6% | ||
| Q3 25 | 3.6% | -163.7% | ||
| Q2 25 | 0.6% | -302.9% | ||
| Q1 25 | 0.3% | -466.3% | ||
| Q4 24 | 0.5% | 54.5% | ||
| Q3 24 | -2.5% | -1051.6% | ||
| Q2 24 | -2.6% | -3068.0% | ||
| Q1 24 | -15.5% | — |
净利率RFILSPRY
| Q4 25 | 0.8% | -147.1% | ||
| Q3 25 | 2.0% | -157.4% | ||
| Q2 25 | -1.3% | -285.6% | ||
| Q1 25 | -1.3% | -425.7% | ||
| Q4 24 | -1.3% | 57.7% | ||
| Q3 24 | -4.2% | -925.0% | ||
| Q2 24 | -26.7% | -2503.2% | ||
| Q1 24 | -10.1% | — |
每股收益（稀释后）RFILSPRY
| Q4 25 | $0.01 | $-0.41 | ||
| Q3 25 | $0.04 | $-0.52 | ||
| Q2 25 | $-0.02 | $-0.46 | ||
| Q1 25 | $-0.02 | $-0.35 | ||
| Q4 24 | $-0.02 | $0.52 | ||
| Q3 24 | $-0.07 | $-0.20 | ||
| Q2 24 | $-0.41 | $-0.13 | ||
| Q1 24 | $-0.13 | $-0.11 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $5.1M | $245.0M |
| 总债务越低越好 | — | $96.4M |
| 股东权益账面价值 | $35.2M | $114.3M |
| 总资产 | $73.0M | $327.7M |
| 负债/权益比越低杠杆越低 | — | 0.84× |
8季度趋势，按日历期对齐
现金及短期投资RFILSPRY
| Q4 25 | $5.1M | $245.0M | ||
| Q3 25 | $3.0M | $288.2M | ||
| Q2 25 | $3.6M | $240.1M | ||
| Q1 25 | $1.3M | $275.7M | ||
| Q4 24 | $839.0K | $314.0M | ||
| Q3 24 | $1.8M | $204.6M | ||
| Q2 24 | $1.4M | $218.7M | ||
| Q1 24 | $4.5M | $223.6M |
总债务RFILSPRY
| Q4 25 | — | $96.4M | ||
| Q3 25 | — | $96.2M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $0 | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益RFILSPRY
| Q4 25 | $35.2M | $114.3M | ||
| Q3 25 | $34.8M | $147.7M | ||
| Q2 25 | $34.2M | $192.3M | ||
| Q1 25 | $34.2M | $229.0M | ||
| Q4 24 | $34.1M | $256.8M | ||
| Q3 24 | $34.1M | $201.0M | ||
| Q2 24 | $34.6M | $215.2M | ||
| Q1 24 | $38.7M | $223.9M |
总资产RFILSPRY
| Q4 25 | $73.0M | $327.7M | ||
| Q3 25 | $73.2M | $372.8M | ||
| Q2 25 | $72.7M | $313.5M | ||
| Q1 25 | $70.4M | $327.3M | ||
| Q4 24 | $71.0M | $351.2M | ||
| Q3 24 | $71.9M | $217.6M | ||
| Q2 24 | $72.8M | $222.0M | ||
| Q1 24 | $79.1M | $227.6M |
负债/权益比RFILSPRY
| Q4 25 | — | 0.84× | ||
| Q3 25 | — | 0.65× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $2.1M | $-43.5M |
| 自由现金流经营现金流 - 资本支出 | $2.0M | — |
| 自由现金流率自由现金流/营收 | 9.0% | — |
| 资本支出强度资本支出/营收 | 0.3% | 0.0% |
| 现金转化率经营现金流/净利润 | 12.13× | — |
| 过去12个月自由现金流最近4个季度 | $4.3M | — |
8季度趋势，按日历期对齐
经营现金流RFILSPRY
| Q4 25 | $2.1M | $-43.5M | ||
| Q3 25 | $-311.0K | $-47.0M | ||
| Q2 25 | $2.2M | $-39.6M | ||
| Q1 25 | $601.0K | $-40.7M | ||
| Q4 24 | $-244.0K | $42.0M | ||
| Q3 24 | $2.4M | $-14.5M | ||
| Q2 24 | $197.0K | $-7.3M | ||
| Q1 24 | $840.0K | $-6.7M |
自由现金流RFILSPRY
| Q4 25 | $2.0M | — | ||
| Q3 25 | $-419.0K | $-47.2M | ||
| Q2 25 | $2.2M | $-39.6M | ||
| Q1 25 | $574.0K | $-40.8M | ||
| Q4 24 | $-418.0K | $41.7M | ||
| Q3 24 | $2.1M | $-14.6M | ||
| Q2 24 | $28.0K | $-7.3M | ||
| Q1 24 | $697.0K | $-6.8M |
自由现金流率RFILSPRY
| Q4 25 | 9.0% | — | ||
| Q3 25 | -2.1% | -145.4% | ||
| Q2 25 | 11.4% | -252.2% | ||
| Q1 25 | 3.0% | -512.1% | ||
| Q4 24 | -2.3% | 48.2% | ||
| Q3 24 | 12.6% | -706.3% | ||
| Q2 24 | 0.2% | -1463.4% | ||
| Q1 24 | 5.2% | — |
资本支出强度RFILSPRY
| Q4 25 | 0.3% | 0.0% | ||
| Q3 25 | 0.5% | 0.6% | ||
| Q2 25 | 0.2% | 0.3% | ||
| Q1 25 | 0.1% | 1.1% | ||
| Q4 24 | 0.9% | 0.3% | ||
| Q3 24 | 1.5% | 6.8% | ||
| Q2 24 | 1.0% | 7.6% | ||
| Q1 24 | 1.1% | — |
现金转化率RFILSPRY
| Q4 25 | 12.13× | — | ||
| Q3 25 | -0.79× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.84× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
RFIL
| US | $20.9M | 92% |
| Non Us | $1.8M | 8% |
SPRY
| Products | $20.3M | 72% |
| Other | $7.8M | 28% |
